These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2501829)

  • 1. The association between apolipoprotein A-I and prostacyclin binding in human serum.
    O'Brien WF; Torres C; Benoit R; Knuppel RA
    Prostaglandins; 1989 Jul; 38(1):45-51. PubMed ID: 2501829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of albumin and non-esterified fatty acids on serum prostacyclin binding in pregnancy.
    O'Brien WF; Saba HI; Knuppel RA; Benoit R; Bruce A
    Prostaglandins; 1989 Jan; 37(1):61-7. PubMed ID: 2655012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.
    Yui Y; Aoyama T; Morishita H; Takahashi M; Takatsu Y; Kawai C
    J Clin Invest; 1988 Sep; 82(3):803-7. PubMed ID: 3047170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prostacyclin binding and half-life in the umbilical circulation.
    O'Brien WF; Knuppel RA; Saba HI; Benoit R; Bruce A
    Prostaglandins; 1988 Feb; 35(2):185-90. PubMed ID: 3283847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prostacyclin binding and half-life in normal and hypertensive pregnant women.
    O'Brien WF; Knuppel RA; Saba HI; Angel JL; Benoit R; Bruce A
    Obstet Gynecol; 1989 Jan; 73(1):43-6. PubMed ID: 2642327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of PGI2 activity by serum proteins: serum albumin but not high density lipoprotein is the PGI2 binding and stabilizing protein in human blood.
    Tsai AL; Hsu MJ; Patsch W; Wu KK
    Biochim Biophys Acta; 1991 Dec; 1115(2):131-40. PubMed ID: 1764464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of prostacyclin by plasma glycoproteins.
    Papp AC; Hall ER; Wu KK
    Prostaglandins; 1985 Dec; 30(6):1057-68. PubMed ID: 3911293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the interaction between prostacyclin and human serum albumin using a fluorescent analogue, 2,6-dichloro-4-aminophenol iloprost.
    Tsai AL; Hsu MJ; Wu KK
    Biochim Biophys Acta; 1989 Oct; 993(1):74-82. PubMed ID: 2478194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
    Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis.
    Kaysen GA; Jones H; Joles JA; van Tol A
    Miner Electrolyte Metab; 1996; 22(1-3):31-8. PubMed ID: 8676821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of prostacyclin in human plasma and whole blood: studies on the protective effect of albumin.
    Orchard MA; Robinson C
    Thromb Haemost; 1981 Oct; 46(3):645-7. PubMed ID: 7031983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization mechanism of prostacyclin by human serum: an approach by binding kinetics using a stable prostaglandin I2 analogue, iloprost.
    Tsai AL; Wu KK
    Biochim Biophys Acta; 1987 Apr; 924(1):67-74. PubMed ID: 2435326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Plasma Albumin, Vitamin D, and Apolipoproteins A and B as Predictive Coronary Risk Biomarkers in the REGICOR Study.
    Vázquez-Oliva G; Zamora A; Ramos R; Subirana I; Grau M; Dégano IR; Muñoz D; Fitó M; Elosua R; Marrugat J
    Rev Esp Cardiol (Engl Ed); 2018 Nov; 71(11):910-916. PubMed ID: 29764762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin-stabilising-factor deficiency in thrombotic thrombocytopenic purpura.
    Mikhailidis DP; Dandona P
    Lancet; 1982 Mar; 1(8273):678-9. PubMed ID: 6121983
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum prostacyclin binding defects in thrombotic thrombocytopenic purpura.
    Wu KK; Hall ER; Rossi EC; Papp AC
    J Clin Invest; 1985 Jan; 75(1):168-74. PubMed ID: 3880771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nonesterified fatty acids on the stability of prostacyclin activity.
    Mikhailidis DP; Mikhailidis AM; Barradas MA; Dandona P
    Metabolism; 1983 Jul; 32(7):717-21. PubMed ID: 6345992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A-I in liver disease.
    Florén CH; Franzén J; Albers JJ
    Scand J Gastroenterol; 1987 May; 22(4):454-8. PubMed ID: 3110938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of apolipoprotein A1 and immunoglobulin as components of a serum complex that mediates activation of human sperm motility.
    Akerlöf E; Jörnvall H; Slotte H; Pousette A
    Biochemistry; 1991 Sep; 30(37):8986-90. PubMed ID: 1909888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of serum prostacyclin stability in ischemic stroke.
    Stein RW; Papp AC; Weiner WJ; Wu KK
    Stroke; 1985; 16(1):16-8. PubMed ID: 3880946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin I2 half-life regulated by high density lipoprotein is decreased in acute myocardial infarction and unstable angina pectoris.
    Aoyama T; Yui Y; Morishita H; Kawai C
    Circulation; 1990 Jun; 81(6):1784-91. PubMed ID: 2111741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.